
Luckily, sarcomas are rare - but this also means that very few clinical trials have investigated better ways to tackle these malignant tumours. The fact that there are many types of sarcoma, which respond to treatment in very different ways, adds to the difficulty of organising such studies. An EU-funded cancer research project has taken up the challenge in a bid to develop targeted treatments.
from EUROPA - Syndicated Research News Feed http://ift.tt/1O32g0G
via
IFTTT
No comments:
Post a Comment